Detalles de la búsqueda
1.
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion.
Diabetes Obes Metab
; 26(1): 215-223, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37814517
2.
Understanding the pharmacokinetics and glucodynamics of once weekly basal insulins to inform dosing principles: an introduction to clinicians.
Endocr Pract
; 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38880349
3.
Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus.
Diabetes Obes Metab
; 25(7): 1964-1972, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36974352
4.
Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase study.
Diabetes Obes Metab
; 24(2): 187-195, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34605142
5.
Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study.
Diabetes Obes Metab
; 24(2): 196-203, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34595812
6.
Postprandial triglyceride reduction following acute treatment of a selective 5-hydroxytryptamine-2c agonist and characterization using a semi-physiological model.
Diabetes Obes Metab
; 23(4): 1001-1010, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368960
7.
Linking categorical models for prediction of pleasantness score using individual predictions of sweetness and creaminess: An advancement of categorical modeling.
J Pharmacokinet Pharmacodyn
; 48(6): 815-823, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196848
8.
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.
Diabetes Obes Metab
; 22(10): 1789-1798, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436641
9.
Sweet/Fat Preference Taste in Subjects Who are Lean, Obese and Very Obese.
Pharm Res
; 37(12): 244, 2020 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33215233
10.
Semi-physiological model of postprandial triglyceride response in lean, obese and very obese individuals after a high-fat meal.
Diabetes Obes Metab
; 20(3): 660-666, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29072819
11.
Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet-Induced Obese Rats.
J Pharmacol Exp Ther
; 362(1): 108-118, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28465372
12.
Frequency and Severity of Hypoglycemia Under Conditions of Increased Hypoglycemic Risk with Insulin Efsitora Alfa Versus Insulin Glargine Treatment in Participants with Type 2 Diabetes.
Diabetes Ther
; 2024 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38907935
13.
Evaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP-1.
CPT Pharmacometrics Syst Pharmacol
; 12(10): 1529-1540, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37667531
14.
Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry.
Anal Biochem
; 423(2): 187-94, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22369892
15.
Impact of Obesity on Postprandial Triglyceride Contribution to Glucose Homeostasis, Assessed with a Semimechanistic Model.
Clin Pharmacol Ther
; 112(1): 112-124, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35388464
16.
Evaluation of the Pharmacokinetic Profile of Ultra Rapid Lispro Administered Subcutaneously at Different Injection Sites.
Clin Ther
; 44(6): 836-847, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577602
17.
Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog® Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data.
Clin Pharmacokinet
; 60(11): 1423-1434, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34041713
18.
Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects.
Diabetes Ther
; 11(8): 1709-1720, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32535742
19.
Pharmacokinetic and Glucodynamic Responses of Ultra Rapid Lispro vs Lispro Across a Clinically Relevant Range of Subcutaneous Doses in Healthy Subjects.
Clin Ther
; 42(9): 1762-1777.e4, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32900535
20.
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial.
Clin Pharmacokinet
; 59(12): 1589-1599, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32468447